Log in to search using one of your social media accounts:

 

Cancer Rates Raised in Patients With Primary Immunodeficiency Diseases
Patients with primary immunodeficiency diseases are at increased risk of certain cancers, according to a new study. The strongest association was with lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - August 3, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Leukemia & Lymphoma News Source Type: news

Celebrating 10 years of success for Infusion
As the business took off, more space was needed, and the company moved in 2009 to “real” office space just up the road in Haddam, CT, across the street from the Connecticut River, eventually employing a staff of 10 that year. A year later, in 2010, Infusion had doubled in size and became part of the UDG/Ashfield family. Infusion continued to grow at a steady pace into new therapeutic areas with more clients and employees, and in October 2016, Infusion left its country setting and moved into larger corporate offices in downtown Middletown, CT. Our staff now comprises 45 people and includes account executives, me...
Source: Ashfield Healthcare News - July 11, 2017 Category: Pharmaceuticals Authors: Sarah Edwards Tags: Ashfield Source Type: news

5 Surprising Things You Didn’t Know About Your Immune System
People often make reference to the immune system when feeling under the weather, but we wondered how many people truly understand the complexities of this internal task force? To put it plainly, the immune system is a network of cells, tissues and organs that work together to protect the body. It is the immune system’s responsibility to tell your body what belongs and what does not. In rare chronic cases, like primary immunodeficiency, the immune system is either missing or isn’t working properly, but for most healthy people, it separates friend from foe ― and responds to enemies (like bacteria, viruses and ...
Source: Healthy Living - The Huffington Post - April 27, 2017 Category: Consumer Health News Source Type: news

Novel Tools for Primary Immunodeficiency Diagnosis Novel Tools for Primary Immunodeficiency Diagnosis
Explore novel deep profiling approaches for the diagnosis and assessment of primary immunodeficiencies.Current Opinion in Allergy and Clinical Immunology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 6, 2017 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Journal Article Source Type: news

Genes Associated With Common Variable Immunodeficiency Genes Associated With Common Variable Immunodeficiency
This review summarizes current knowledge regarding the molecular genetic basis of common variable immunodeficiency, one of the most prevalent primary immunodeficiencies.Journal of Medical Genetics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 16, 2016 Category: Allergy & Immunology Tags: Pathology & Lab Medicine Journal Article Source Type: news

Rubella virus persists after vaccination in some patients with immunodeficiency disorders
Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine. Although the vaccine for rubella (German measles) has an established record of safety and effectiveness in the general population, patients with severe deficiencies in their immune defenses may be susceptible to side effects from the vaccine, say researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 4, 2016 Category: Science Source Type: news

Rubella virus persists after vaccination in some patients with rare immune disorders
(Children's Hospital of Philadelphia) Some patients with rare primary immunodeficiency disorders may at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine. Although the vaccine for rubella (German measles) has an established record of safety and effectiveness in the general population, patients with severe deficiencies in their immune defenses may be susceptible to side effects from the vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 4, 2016 Category: Global & Universal Source Type: news

Factor Lifestyle Into Immunodeficiency Treatment Choice Factor Lifestyle Into Immunodeficiency Treatment Choice
Patients with primary immunodeficiency disease should be asked about their lives, family, and work before a treatment regimen is chosen, and the discussion should be revisited as circumstances change.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2016 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

FDA OKs Immune Globulin Cuvitru for Primary Immunodeficiency FDA OKs Immune Globulin Cuvitru for Primary Immunodeficiency
Approval of immune globulin subcutaneous 20% solution follows positive data on efficacy and safety, as well as infusion time and number of injections sites.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2016 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news

Shire Announces FDA Approval of Cuvitru [immune globulin subcutaneous (human)] for Primary Immunodeficiency
Lexington, Mass. – September 14, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the United States Food and Drug Administration (FDA) has granted approval for Cuvitru [Immune Globulin Subcutaneous (Human), 20% Solution] in adult and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 14, 2016 Category: Drugs & Pharmacology Source Type: news

Primary Immunodeficiency Disease (PIDD)
Title: Primary Immunodeficiency Disease (PIDD)Category: Diseases and ConditionsCreated: 8/1/2016 12:00:00 AMLast Editorial Review: 8/1/2016 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - August 1, 2016 Category: Pediatrics Source Type: news

Cancer Diagnosed More Often in Patients with Primary Immunodeficiency Diseases
Researchers evaluated the overall and site-specific incidence of cancer among patients registered in USIDNET, and found increased cancer incidence rates, especially in lymphomas, among patients with primary immunodeficiency diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 6, 2016 Category: Science Source Type: news

4th national workshop on primary immunodeficiency diseases inaugrated
The fourth national workshop on primary immunodeficiency diseases was inaugurated today at the Centrally sponsored JIPMER here. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 18, 2015 Category: Pharmaceuticals Source Type: news

Identified the epigenetic basis of CVID through the study of identic twins
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers of the Chromatin and Disease Group from the Bellvitge Biomedical Research Institute (IDIBELL) and La Paz Hospital (IDIPAZ) have identified epigenetic alterations in Common Variable Immunodeficiency (CVID), the most common primary immunodeficiency, using as a starting point genetically identical monozygotic twins discordant for the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 17, 2015 Category: Global & Universal Source Type: news

Baxter introduces subcutaneous immunoglobulin treatment Hyqvia in US
Baxter International and Halozyme Therapeutics have announced the launch of Hyqvia in the US, a subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 21, 2014 Category: Pharmaceuticals Source Type: news

FDA approves Hyqvia to treat primary immunodeficiency
Baxter and Halozyme have received approval from the US Food and Drug Administration (FDA) for Hyqvia to treat adult patients with primary immunodeficiency (PI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 14, 2014 Category: Pharmaceuticals Source Type: news

Jeffrey Modell Foundation supports Belgian research on primary immunodeficiency
(VIB (the Flanders Institute for Biotechnology)) For the first time the Jeffrey Modell Foundation is giving a research grant to a Belgian laboratory. The team of Adrian Liston from VIB-KU Leuven will use the grant to develop a gene therapy to cure children that suffer from IPEX syndrome, a rare and fatal autoimmune disorder in which the immune system attacks the body's own tissues and organs. At the moment, the only successful therapy to treat the syndrome is a bone marrow transplantation, which is not available for all children. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 9, 2014 Category: Global & Universal Source Type: news

Baxter files modified BLA to FDA for HyQvia for treatment of primary immunodeficiency
Baxter International has filed an amended biologics license application (BLA) to the US Food and Drug Administration (FDA) to re-start the review process for approval of HyQvia facilitated subcutaneous infusion for the treatment of adult patients wit… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - December 5, 2013 Category: Pharmaceuticals Source Type: news

Human immune system shapes skin microbiome
Our skin plays host to millions of beneficial and potentially disease-causing microorganisms; however, whether our immune system influences these microbial communities to prevent disease is unknown. In a study published online in Genome Research, researchers have explored the microbes living on the skin of patients with primary immunodeficiencies with eczema-like skin conditions. The human body contains many microbes, some of which are necessary for healthy bodily functions including digestion. Others, such as some microbes living on our skin, may be pathogenic... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2013 Category: Consumer Health News Tags: Dermatology Source Type: news

GI Disorders in Patients With Primary ImmunodeficiencyGI Disorders in Patients With Primary Immunodeficiency
The gastrointestinal tract is the largest lymphoid organ in the body, so it is not surprising that intestinal diseases are common among immunodeficient patients. Clinical Gastroenterology and Hepatology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 7, 2013 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news

CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Larger Vial Size Is Another Convenience Offering for People Managing Primary Immunodeficiency with Hizentra KING OF PRUSSIA, Pa., Sept. 3, 2013 -- (Healthcare Sales & Marketing Network) -- CSL Behring today announced that the U.S. Food and Drug Adminis... Biopharmaceuticals, FDACSL Behring, Hizentra, Immune Globulin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 3, 2013 Category: Pharmaceuticals Source Type: news

Immunoglobulin Market (PI & CIDP ) Analysis and Forecasts to 2019...
“Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) potentially supplemented by approvals for Alzheimers disease” is...(PRWeb May 27, 2013)Read the full story at http://www.prweb.com/releases/immunoglobulin-market/pi-cidp-analysis-2019/prweb10772086.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 29, 2013 Category: Pharmaceuticals Source Type: news

Clinical Cases in Primary Immunodeficiency Diseases
A Problem-Solving ApproachPrimary immunodeficiency diseases (PIDs) are a heterogeneous group of inherited disorders characterized by different defects in the development and function of the immune system. These defects render patients susceptible to a variety of infectious diseases. Knowledge of normal immunity and specific warning signs and symptoms can help physicians to identify those children with underlying ... (Source: Springer Biomedical Sciences titles)
Source: Springer Biomedical Sciences titles - January 11, 2013 Category: Biomedical Science Tags: Immunology Source Type: news